Brain Cancer Perspective

 
 
  • 10 Ways to Say No to Patients -- and Still Keep Them Smiling It's not easy to refuse patient requests for drugs, tests, or studies that aren't indicated when you might wind up with an unhappy patient or a negative online review. Here's how some doctors do it.
  • 5 Hot Topics in Epilepsy Care Dr Wilner discusses highlights from the recent American Epilepsy Society Annual Meeting.
  • Systemic Options for Treating Brain Metastases The therapeutic challenge of brain metastases in lung cancer, breast cancer, and melanoma is being met by a growing number of systemic therapies, as highlighted in an integrated session of ECC 2015.
  • Pediatric Primary Headache From A to Z A special symposium at this year's PAS addressed pediatric headache and migraine, emphasizing the need to approach them as functional problems.
  • Can Orgasmic Sensations Signal Cancer? An interesting case report looks at the link between orgasmic aura and brain pathology.
  • Today's Cancer Research Pioneers More than 50 years after the introduction of chemotherapy, a new wave of researchers seek to radically advance cancer treatments.
  • Mythbusters: Does This Cause Cancer? Five commonly cited environmental cancer risks are investigated to determine how robust the link to cancer actually is.
  • Medical Marijuana: The State of the Science In this comprehensive review of the literature, Dr Michael Schatman discusses the available evidence and current controversies surrounding the use of cannabinoids in medicine.
  • AHAMagnaSafe Proves Most Device Patients Safe in MRI Scanner Dr Melissa Walton-Shirley relates the results of the MagnaSafe registry and makes a plea for healthcare providers and device makers to pay attention.
  • Terminally Ill Woman Chooses Suicide   A 29-year-old woman with brain cancer has moved to Oregon and vowed to kill herself, with her doctor's help. Her youth and appeal may change the nature of the debate on physician-assisted suicide.
  • Crack the Case: Worsening Headaches and Nausea What do this patient's MRI and neuropathologic findings suggest as a diagnosis?
  • Why Is So Much of the Medical Literature Wrong? Dr. Labos reviews the pitfalls of epidemiologic research and why a lot of published findings should be taken with a grain of salt.
  • Soft Tissue Sarcoma Guidelines: Updated and 'Irradiated' With more than 12,000 cases and almost 5000 deaths yearly, soft-tissue sarcoma is owed greater attention, as revised guidelines and perspectives from experts attest.
  • Save Cancer Trials From the NCI Slasher   NCI budget cuts to 2 clinical trial programs endanger patients and cripple research, says Dr. Bruce Cheson, who calls for the feds to loosen their stranglehold on clinical trials.
  • The Infant With an ALTE: How Much Workup? Every pediatric, family medicine, and ED clinician has been faced with an infant who 'turned blue,' 'choked,' or 'stopped breathing,' but looks fine now. How much workup is warranted?
  • Topol on 'What's Up' in Medicine Medscape Editor-in-Chief Eric Topol details the latest research and news of interest to practicing clinicians.
  • Bevacizumab: Mixed Results in Glioblastoma   Prof. Wolfgang Wick reviews the neuro-oncology highlights from ECC 2013, focusing on glioblastoma and mixed results of bevacizumab trials.
  • XXI World Congress of Neurology (WCN) Read clinically focused news coverage of key developments from WCN 2013.
  • 2013 Annual Meeting of the American Society of Clinical Oncology® Read clinically focused news coverage of key developments from ASCO® 2013.
  • ASCO Plenary Session: Not Your Usual Suspects   Dr. Kathy Miller previews the exceptional studies to be presented at the ASCO plenary session, ranging from rare tumors of the brain and thyroid to a screening strategy that has global implications.